| |
| |
|
| Insider
Information: |
Misfeldt Dayton |
| Relationship: |
Director |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
30,708 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$23,338 |
|
|
| Total
Shares |
30,708 |
|
|
| Total
Value |
$23,338 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Viracta Therapeutics Ord Shs |
VIRX |
Director |
|
0 |
2017-10-27 |
30,708 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2017-10-27 |
4 |
B |
$2.00 |
$800,000 |
I/I |
400,000 |
30,456 |
2.1 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2015-12-21 |
4 |
B |
$0.84 |
$1,470,000 |
I/I |
1,750,000 |
137,859 |
2.1 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2015-07-24 |
4 |
S |
$3.46 |
$2,200,242 |
I/I |
(635,702) |
105,134 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2015-07-24 |
4 |
OE |
$1.32 |
$2,198,896 |
I/I |
1,665,830 |
109,096 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • • |
2014-08-28 |
4 |
S |
$7.89 |
$1,577,020 |
I/I |
(200,000) |
85,872 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • • |
2014-08-27 |
4 |
S |
$8.16 |
$822,014 |
I/I |
(100,700) |
89,612 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • • |
2014-08-12 |
4 |
S |
$6.77 |
$251,230 |
I/I |
(37,100) |
91,495 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • • |
2014-08-11 |
4 |
S |
$6.90 |
$218,103 |
I/I |
(31,600) |
92,189 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • • |
2014-08-08 |
4 |
S |
$6.62 |
$4,468,568 |
I/I |
(675,000) |
92,780 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • • |
2010-06-30 |
4 |
A |
$0.00 |
$0 |
I/I |
9,994,990 |
632,416 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • • |
2010-06-30 |
4 |
B |
$0.28 |
$6,551,724 |
I/I |
23,824,450 |
445,516 |
2.25 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • • |
2009-04-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
9,091 |
|
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
